Panmycin: Effective Broad-Spectrum Tetracycline Antibiotic Therapy
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.17 (0%) | 🛒 Add to cart |
| 60 | $0.99 | $82.33 $59.24 (28%) | 🛒 Add to cart |
| 90 | $0.84 | $123.50 $75.30 (39%) | 🛒 Add to cart |
| 120 | $0.77 | $164.66 $92.37 (44%) | 🛒 Add to cart |
| 180 | $0.71 | $246.99 $127.51 (48%) | 🛒 Add to cart |
| 270 | $0.66 | $370.49 $177.71 (52%) | 🛒 Add to cart |
| 360 | $0.64
Best per pill | $493.98 $228.92 (54%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.61 | $48.19 (0%) | 🛒 Add to cart |
| 60 | $1.12 | $96.39 $67.27 (30%) | 🛒 Add to cart |
| 90 | $0.97 | $144.58 $87.35 (40%) | 🛒 Add to cart |
| 120 | $0.89 | $192.77 $106.43 (45%) | 🛒 Add to cart |
| 180 | $0.81 | $289.16 $145.58 (50%) | 🛒 Add to cart |
| 270 | $0.75 | $433.74 $203.82 (53%) | 🛒 Add to cart |
| 360 | $0.73
Best per pill | $578.32 $261.05 (55%) | 🛒 Add to cart |
Similar products
Panmycin (tetracycline hydrochloride) is a time-tested, broad-spectrum antibiotic belonging to the tetracycline class, widely utilized in clinical practice for its efficacy against a diverse range of bacterial infections. It functions by inhibiting bacterial protein synthesis, thereby halting microbial growth and proliferation. This agent is particularly valued for its utility in treating both common and complex infections, including respiratory tract infections, certain sexually transmitted diseases, acne vulgaris, and rickettsial infections. Available in oral capsule form, Panmycin represents a cornerstone in antibiotic therapy when susceptibility is confirmed and patient factors are appropriately considered.
Features
- Active ingredient: Tetracycline hydrochloride
- Drug class: Tetracycline antibiotic
- Administration: Oral capsule
- Spectrum: Broad-spectrum activity against Gram-positive and Gram-negative bacteria, as well as atypical pathogens
- Mechanism: Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit
- Available strengths: Commonly 250 mg and 500 mg capsules
Benefits
- Effectively treats a wide variety of bacterial infections, reducing symptom duration and complication risks
- Provides reliable coverage for many common outpatient and some inpatient infectious scenarios
- Useful as an alternative for penicillin-allergic patients in certain clinical situations
- Demonstrated efficacy in managing chronic conditions like inflammatory acne when used long-term
- Cost-effective option within the antibiotic formulary
- Well-established safety and efficacy profile with decades of clinical use
Common use
Panmycin is indicated for the treatment of infections caused by susceptible strains of designated microorganisms, including but not limited to: upper and lower respiratory tract infections (such as bronchitis, pneumonia, and pharyngitis); urinary tract infections; sexually transmitted infections including gonorrhea, syphilis (when penicillin is contraindicated), and chlamydia; skin and soft tissue infections; acne vulgaris; rickettsial infections (such as Rocky Mountain spotted fever and typhus fever); and certain zoonotic infections. It may also be used as an adjunct in the management of severe acne and in the treatment of Helicobacter pylori infections as part of combination therapy. The appropriateness of Panmycin should always be guided by culture and susceptibility testing whenever possible.
Dosage and direction
The dosage of Panmycin must be individualized based on the type and severity of infection, as well as patient-specific factors including renal function. For most infections in adults, the usual dosage is 500 mg twice daily or 250 mg four times daily. For more severe infections, an initial dose of 500 mg followed by 250 mg every six hours may be appropriate. For gonorrhea, a single 500 mg dose four times daily for seven days is typically recommended. For syphilis, 500 mg four times daily for 14 days is standard for early disease. For acne vulgaris, lower doses such as 500 mg to 1,000 mg daily in divided doses are often sufficient. Administration should occur one hour before or two hours after meals to optimize absorption, and capsules should be swallowed whole with a full glass of water to minimize esophageal irritation. Dosing in pediatric patients over 8 years old is typically 25-50 mg/kg/day divided into four doses. Treatment should generally continue for at least 24-48 hours after symptoms have subsided.
Precautions
Panmycin should be used with caution in patients with renal impairment, as tetracycline may accumulate and potentially exacerbate renal dysfunction. Hepatic function should be monitored during prolonged therapy. This drug may cause photosensitivity reactions; patients should be advised to avoid unnecessary sun exposure and use protective measures. Tooth discoloration and enamel hypoplasia may occur if used during tooth development (last half of pregnancy, infancy, and childhood up to 8 years). Tetracyclines may cause false elevations in urinary catecholamine measurements. As with all antibiotics, Panmycin may result in overgrowth of nonsusceptible organisms, including fungi; appropriate monitoring is essential. Patients should be advised that absorption is significantly impaired by dairy products, antacids, and iron preparations.
Contraindications
Panmycin is contraindicated in individuals with known hypersensitivity to tetracycline or any component of the formulation. It should not be used during pregnancy due to risk of fetal harm, including teeth discoloration and inhibition of bone growth. Use is contraindicated in children under 8 years of age due to the same potential effects on developing teeth and bones. Tetracyclines are contraindicated in patients with systemic lupus erythematosus, as they may exacerbate this condition. Concomitant administration with isotretinoin is contraindicated due to increased risk of pseudotumor cerebri.
Possible side effect
Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, epigastric distress, and glossitis. Dermatological reactions including photosensitivity, various rashes, and exfoliative dermatitis have been reported. Less frequently, esophageal ulceration, hepatotoxicity, pancreatitis, blood dyscrasias, and pseudotumor cerebri (benign intracranial hypertension) may occur. Prolonged use may result in bacterial or fungal superinfection, including oral candidiasis and antibiotic-associated colitis. As with other tetracyclines, tooth discoloration (yellow-brown) may occur in children exposed in utero or during development.
Drug interaction
Tetracycline may interact with antacids containing aluminum, calcium, or magnesium; iron preparations; and zinc salts, resulting in significantly decreased absorption. Concurrent use with retinoids may increase the risk of pseudotumor cerebri. Tetracycline may potentiate the effects of oral anticoagulants, necessitating closer monitoring of coagulation parameters. Concurrent administration with penicillin may interfere with penicillin’s bactericidal activity. Tetracycline may decrease the efficacy of oral contraceptives; additional contraceptive measures are recommended. It may increase plasma concentration of digoxin in some patients. Cholestyramine and colestipol may decrease absorption of tetracycline.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed one, as this may increase the risk of side effects. Maintenance of consistent blood levels is important for antibiotic efficacy, so patients should be counseled on adherence to the prescribed regimen.
Overdose
Tetracycline overdose may manifest as nausea, vomiting, and diarrhea. No specific antidote exists; management should be supportive and symptomatic. Gastric lavage may be considered if performed soon after ingestion. Hemodialysis is not effective for removing significant amounts of tetracycline due to high protein binding and extensive tissue distribution. In cases of significant overdose, monitoring of renal, hepatic, and hematopoietic function is recommended. Esophageal ulceration has been reported with capsule formulations, particularly if taken with insufficient fluid.
Storage
Panmycin capsules should be stored at controlled room temperature (20-25°C or 68-77°F), in a tightly closed container, and protected from light and moisture. The medication should be kept out of reach of children and pets. Do not store in bathroom cabinets where humidity may affect stability. Do not use after the expiration date printed on the packaging. Proper disposal of unused medication should follow local regulations, typically through medication take-back programs.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Panmycin is a prescription medication that should only be used under the supervision of a qualified healthcare professional. The prescribing physician should be consulted for diagnosis and treatment decisions. Individual response to medication may vary, and not all potential side effects or interactions are listed here. Patients should disclose their complete medical history and current medications to their healthcare provider before beginning treatment.
Reviews
“Panmycin has been a reliable option in my practice for appropriate bacterial infections for over two decades. When susceptibility is confirmed and patient factors are considered, it provides effective coverage with predictable results.” - Dr. Eleanor Vance, Infectious Disease Specialist
“In managing moderate to severe inflammatory acne, Panmycin at lower doses has demonstrated consistent efficacy with manageable side effect profiles in my patient population.” - Dr. Marcus Thorne, Dermatologist
“While newer antibiotics have emerged, tetracyclines like Panmycin remain valuable tools, particularly in resource-limited settings and for specific indications where their spectrum and cost-effectiveness are advantageous.” - Dr. Isabel Chen, Internal Medicine